ZNTL

Zentalis Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 4/10
  • Momentum↑ 8/10
Zentalis Pharmaceuticals sales and earnings growth
ZNTL Growth
Neutral
  • Revenue Y/Y↓ -200.00%
  • EPS Y/Y↑ 16.87%
  • FCF Y/Y↑ 22.46%
Zentalis Pharmaceuticals gross and profit margin trends
ZNTL Profitability
Fair
  • Gross margin ↑ 100.00%
  • EPS margin↑ 368.10%
  • ROIC↓ -45.80%
Zentalis Pharmaceuticals net debt vs free cash flow
ZNTL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Zentalis Pharmaceuticals stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗